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Estimating the integrity of aged DNA
samples by CE
A CE/UV method was developed to separate by a micellar system the four DNA bases
and other five purinic–pyrimidinic compounds (5-methyl-cytosine, uracil, xanthyne,
hypoxanthyne and 5-bromo-uracil). Selectivity, precision, accuracy and sensitivity were
assessed and proved to be suitable for the analysis of the primary structure of DNA. This
method was adopted to study 16 aged samples including two Egyptian mummies,
formaldehyde-fixed paraffin-embedded tissues and other forensic specimens. Lower
relative values of the four canonical unmodified DNA bases (uDNAb) and more complex
pherograms were found in the aged samples when compared with the modern controls.
The results of the CE analysis, together with those obtained by classical molecular
methods (agarose gel electrophoresis, DNase I and RNase A assays, and UV spectro-
photometry), were finally evaluated for assessing the reliability of STR typing. Since
samples with low uDNAb showed no amplification or unreliable STR profiles, the
uDNAb value is discussed as a further quality criterion in the evaluation of the genetic
data obtained from aged samples.
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1 Introduction
Genetic typing is usually performed by PCR, an error-prone
in vitro DNA amplification technique [1]. PCR has been
adopted since the beginning of the 1990s, and it represents a
common method to acquire genetic results from a variety of
different biological samples. In particular, PCR is the only
technique by which genetic data can be gathered from aged
biological samples such as museum specimens, tissues
archives, and forensic samples [2, 3]. However, PCR fidelity
is influenced by several factors (source of the polymerase,
buffer composition, primers design, etc.) with the amount
and the integrity of the genetic template playing the major
role [1, 4, 5]. In addition, since a high number of PCR cycles
(35–40 cycles) is usually necessary to amplify low amounts
of DNA, PCR artefacts and contaminations can sometimes
be originated. These undesired amplification products may
represent important sources of mistyping potentially giving
false profiles, as it is impossible to distinguish them from
authentic replicates of the original DNA.
These critical issues and the strong need for authenticity
criteria on the reliability of genetic results are well recog-
nised in most biomedical application fields but emphasised
especially in ancient DNA (aDNA) studies [2, 3, 6–10].
The investigation of post mortem tissues shows that DNA
decay spontaneously occurs [11] and it inevitably accumu-
lates [12–17]. As further matter of complication, chemicals
used for sample preservation such as formaldehyde, for
instance, are well-defined agents that cause DNA modifica-
tions [18]. The molecular composition of aged DNA samples
has been already studied by different methods, including
GC/MS [19] and reversed-phase HPLC/MS [17, 20].
Although the adoption of MS-based techniques provides
highly reliable results, they are still not applicable in routine
practice of DNA analysis either because of their overall
complexity, or due to the limited amounts of genetic mate-
rial that can be recovered from aged samples.
In the past years, CE has been successfully used to solve
crucial concerns in fields such as urinary cancer biomarkers
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determination [21], DNA adducts analysis [22], and inherited
disorders [23–32]. For this reason, we evaluated a possible
application in the forensic field, setting up a CE-based
method to investigate the integrity of the primary structure
of DNA recovered from aged biological samples.
The aim of the present study is to evaluate if the CE
analysis of the DNA primary structure, together with other
tests routinely applied in forensic DNA investigations, could
bring to trustful decisions on the reliability of STR profiles
obtained from aged biological samples.
2 Materials and methods
2.1 Chemicals
Cytosine (C), Guanine (G), Thymine (T), Adenine (A),
Uracil (U), 5-methyl-cytosine (5-met-C), xanthyne (X),
hypoxanthyne (H) and 5-bromo-uracil (5-Br-U) were
purchased from Sigma (Sigma-Aldrich, MO, USA) and
were of 98% minimum certified purity. Concentrated HCl
(37%, w/v), NaOH pearls, sodium tetraborate, sodium
phosphate monobasic, SDS, and water were analytical-grade
reagents obtained from Fluka (Sigma-Aldrich).
2.2 Standard reference solutions
Aliquots of each pure substance (C, G, T, A, U, 5-met-C, X,
H, and 5-Br-U) were dissolved in 1% HCl (v/v) in order to
obtain the concentration of 200 mmol/L each (solution
named master standard mix (MSM)).
A test standard solution (TSS) at the level of 200 mmol/L
of C, G, T, and A was prepared dissolving the corresponding
pure substances in 1% HCl (solution named TSS200). Lower
level reference solutions were obtained by diluting TSS200
with 1% HCl at 100, 50, 25, and 12 mmol/L (Table 1).
A working standard solution at the level of 500 mmol/L
of U, X, H and 5-met-C (4MBS) was prepared in aqueous
1% HCl (v/v) for qualitative analysis of aged samples. All
these solutions were stored at –201C in the dark until use.
2.3 CE/UV apparatus and analytical conditions
A MDQ (Beckman Coulter, CA, USA) apparatus was
employed for this work. The CE system was operated at
254 nm detection wavelength, using an uncoated fused
silica capillary (length 57 cm; 50 mm internal diameter;
window at 50 cm) run at 20 KV for 35 min at 351C in 0.05 M
sodium tetraborate, 0.1 M sodium phosphate monobasic
and 0.3 M SDS buffer adjusted to pH 8.4 by the addition of
1N NaOH drops. The buffer was filtered through a 0.2 mm
nylon GD/X Syringe Filter (Whatman International, UK)
and stored at room temperature until use. Under these
working conditions, a current of up to 188 mA is generated.
Before each injection, the capillary was washed for 3 min
with water, 3 min with 0.1N NaOH and conditioned for
3 min with the running buffer at the pressure of 20.0 psi. All
samples were injected at 0.5 psi for 15 s (corresponding to
an injection volume of 18 nL). Raw data of the analyses were
processed by the Beckman Karat (version 5.0) software after
8 min of run.
The precision of the present procedure was investigated
by injecting the scalar dilutions of TSS200 reported above.
The choice of 5-Br-U as internal standard allowed identify-
ing all injection problems potentially originated by pressure
failure or capillary obstruction.
The sensitivity of the method (S/N 3:1) was tested up to
1.5 mmol/L by analysing scalar dilutions of TSS200.
In order to monitor the analytical performance, at the
beginning of every session MSM was tested. Analytical
precision of peak areas and migration times under these
working conditions were verified also by testing both TSS200
and TSS25 on within and between replicate run analyses.
2.4 Samples
Samples were selected based on the availability of enough
specimens to ensure that all experiments could be repeated
at least in duplicate tests. The 16 samples analysed in this
study are listed in Table 2 together with the biological
sources (tissues) and their estimated dating. In particular,
seven forensic samples (f-samples, aged from 0.1 to 20
years) and five formaldehyde-fixed paraffin-embedded
(FFPE) tissues (aged from 5 to 12 years) were considered.
Out of the forensic samples, two were previously studied by
HPLC/MS (f-PI1 and f-PI3) [17]. Muscle specimens collected
from two Egyptian mummies (samples MD and MF, dated
about 2100 and 2600 years, respectively) were chosen as
ancient samples. In addition, DNA was extracted from buffy
coat prepared from a large blood donation unsuitable for
clinical purposes (sample C13) stored at room temperature
for 2 wk; the same DNA was then stored at 141C with
prolonged expositions at room temperature for more than
one year in order to obtain a naturally spoiled sample
(sample C13X). Ten fresh blood samples collected from
different healthy volunteers were used as control.
2.5 Sample processing
2.5.1 DNA extraction
Before DNA extraction, FFPE samples were sliced into
20 mm sections and treated twice with xylene for 5 min
followed by ethanol washing from 100 to 70%. The bone
samples were incubated in 0.5 M Na2EDTA for 18 h at room
temperature while the specimens from Egyptian mummies
were re-hydrated in water for 18 h at room temperature.
DNA was recovered from all samples using a standard
organic extraction protocol based on phenol/chloroform
purification and ethanol precipitation [33]. All these DNA
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samples were further purified through Ultracel 100 K Amicon
Ultra columns (Millipore, MA; USA). All the recommended
precautions to avoid contamination were followed. Blank
controls were introduced alongside the purification steps.
No ultrafiltration has been carried out on the fresh control
blood samples and on sample C13.
The molecular weight (MW) of the extracted DNAs was
visualised on a 1.2% agarose gel by electrophoresis by
comparison with two MW markers (l/HindIII and Easy
Ladder purchased from Bioline, UK). In order to show that
the UV fluorescence of the samples could be ascribed to the
presence of nucleic acids, a small aliquot of each extract was
incubated with 1U of DNaseI for 1 h at 371C. After incuba-
tion, the DNase-treated samples were run through agarose
gels side by side to the untreated samples. Positive and
negative controls were performed. In addition, some aged
sample was incubated with RNase A (10 mg for each sample)
for 1 h at 371C and run in agarose gels.
2.5.2 DNA quantification
One microliter aliquots from each DNA sample were
quantified using a NanoDrop ND-1000 (Thermo Fisher
Scientific, MA, USA) spectrophotometer. Absorbance at
OD260 and OD280 was determined for each sample at least in
triplicate measurements.
In order to assess the amount of human amplifiable
DNA, 40–50 ng of each sample were used to carry out a Real-
Time PCR quantitative assay using the QuantifilerTM Human
DNA Quantification kit (Applied Biosystems, Foster City, CA,
USA) [http://www3.appliedbiosystems.com/cms/groups/
applied_markets_support/documents/generaldocuments/
cms_041395.pdf]. This kit allows the simultaneous amplifi-
cation of a 62 bp human-specific sequence within the telo-
merase reverse transcriptase gene (hTERT) and a synthetic
internal positive control (IPC) probe (IPC of amplification)
included to determine the presence of inhibitors in the
amplification reactions. The Real-Time assays were
performed on an ABI PRISMs 7700 instrument (Applied
Biosystems) in two replicate tests. Negative PCR controls
were included together with blank extraction controls.
2.5.3 Hydrolysis
DNA can be hydrolysed either by enzymatic or heat-acid
procedures [34]. Aged DNA samples can be scarcely
sensitive to the enzymatic activity of the DNaseI [33, 35],
therefore a heat-acid protocol has to be adopted for these
samples. Although this protocol itself causes a further, albeit
low, DNA damage [34], all the experiments were performed
in formic acid (90%, v/v) at 1701C for 30 min as lower
temperatures (140, 110, and 801C) gave unsatisfactory yields
of hydrolysis especially concerning the pyrimidimic
compounds [36, 37].
To establish the amount of DNA needed for CE analysis,
scalar amounts of human DNA ranging from 10 mg to 50 ng
were analysed. Therefore, it was chosen to hydrolyse DNA
amounts ranging from 2 to 5 mg for each sample in a final
volume of 500–800 mL 90% (v/v) formic acid in screw-capped
glass tubes. Blank hydrolysis controls were introduced in
every batch of reactions. Negative extraction controls were
also tested. After this treatment, the samples were lyophi-
lised by a Concentrator 5301 (Eppendorf International,
Germany) at 601C.
2.6 CE/UV analysis of hydrolysed DNA samples
After hydrolysis and lyophilisation, the DNA samples were
resuspended in 25 mL of 1% HCl with 200 mmol/L of
dissolved 5-Br-U and analysed as reported above in replicate
Table 1. Calibration data, linearity range, sensitivity, accuracy, and intra-day precision of the CE method
TSS Cytosine Guanine Thymine Adenine
Concentration Cmeasured7SD REC7SD Cmeasured7SD REC7SD Cmeasured7SD REC7SD Cmeasured7SD Cmeasured7SD
(mmol/L) (mmol/L) (%) (mmol/L) (%) (mmol/L) (%) (mmol/L) (%)
200 20074 10072 20073 10072 19975 10073 20074 10072
100 99.670.4 99.670.4 10074 10074 10172 10172 10073 10073
50 49.970.1 99.770.2 5173 10275 5173 10275 5073 10076
25 24.670.3 9871 2472 95710 2673 105710 2472 9778
12 12.770.2 10672 1272 101721 1073 82722 1272 104718
LRE y5 63x18 y5 145x–228 y5 75x–145 y5 157x–300
r2 40.999 40.999 40.999 40.999
LOQ (S/N410) 12 12 12 12
LOD (S/N43) 2.0 1.8 2.9 1.6
For every single analyte are shown the concentrations measured together with their standard deviation (Cmeasured7SD) and the
corresponding recoveries and relative standard deviation percent (REC7SD). LRE: linear regression equation calculated on peak areas
(y) versus analyte concentrations (x) in the range of 200–12 mmol/L. r2: square value of the correlation coefficient obtained from the linear
correlation of peak areas and analyte concentrations. All data presented are calculated as mean of at least three measurements.
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runs. To determine the qualitative assessment of the
analytical recovery, the aged samples were spiked with
1/10 (v/v) of 4MBS in six selected cases.
The amount of unmodified DNA bases (uDNAb) was
calculated by the formula: (aT1aC1aG1aA)/[aTot–a(5–B-
r–U)], where a is the peak area of each substance as
measured by the Karat software and aTot is the total area
obtained by the sum of the areas of all peaks detected at
254 nm after 8 min of run. The method accuracy was eval-
uated calculating the analytical recoveries of the released
bases obtained after the hydrolysis of known amounts of
modern control DNAs.
2.7 STR typing
The STR analysis was carried on eleven samples wherein
the presence of amplifiable human DNA was assessed in the
reliability range of QuantifilerTM Human DNA Quantifica-
tion kit.
After quantification by Real-Time PCR, 500 pg of
each DNA sample were initially amplified using the
AmpF/STR IdentifilerTM kit (Applied Biosystems) for 30
cycles of PCR, in duplicate experiments. A second round
of STR typing PCRs was set up on amounts of DNA
increased to 2 ng, only for those samples with sufficient
genetic material. Samples E3, E6, E7 resulted to contain
DNA amounts lower than 500 pg, therefore were split in
two aliquots each one analysed in a different replicate
amplification.
Positive controls (500 pg of high MW DNA) were
simultaneously amplified as well as negative controls (no
DNA). One microliter of each amplified sample was run on
an ABI Prism 310 Genetic analyser (Applied Biosystems),
according to the manufacturer’s specifications. Electro-
pherograms were analysed using a Gene Mapper ID v3.2
(Applied Biosystems) software for allelic sizing. The cut-off
for an unambiguous allele call was set up to 4100 relative
fluorescence units.
Table 2. Samples studied and analytical results
Sample Source Age (years) MW (Kb) DNaseI 260/280 UV/RT [C1G]/4B uDNAb STR analysis
2A FFPE 12 o 0.4 – 1.89 – 0.752 0.672 –
3B FFPE 12 o 0.4 – 2.14 – 0.685 0.667 –
4B FFPE 12 o 0.4 – 2.07 – 0.707 0.686 –
MD muscle 2100 o 0.2 1/– 0.53 – 0.658 0.329 –
MF muscle 2600 o 0.2 1/– 1.12 – 0.626 0.631 –
f-PI1 muscle 0.1 o 23 1 1.64 1.2 0.623 0.876 f.p.
f-PI3 muscle 0.1 o 23 1 1.79 1.7 0.442 0.986 f.p.
f-E3 ligament 1 o 2 1/-- 1.47 6985 0.557 0.862 n.p.
f-E4 liver 0.1 o 2 1 1.54 4.8 0.442 0.959 f.p.
f-E5 bone 15 o 9 1 2.02 364 0.560 0.095 u.p.
f-E6 bone 15 o 9 1 2.19 3711 0.561 0.485 u.p.
f-E7 bone 20 o 23 1 2.22 3921 0.611 0.261 u.p.
E9 FFPE 5 o 2 1/-- 1.42 69.1 0.667 0.813 p.p.
E10 FFPE 8 o 6 1/-- 1.40 142.5 0.545 0.821 n.p.
C13 buffy coat 0.05 o 1.5 1 1.64 3.2 0.402 0.989 f.p.
C13X DNA 1.6 o 0.4 1 1.59 72.3 0.405 0.974 u.p
CTRL blood – 423 1
Mean7SD 1.8470.02 1.270.8 0.4070.01 0.99570.007 f.p.
Max 1.86 3.2 0.41 0.999
Min 1.80 0.5 0.38 0.975
N 10 10 10 10
Sample: laboratory coding of the samples analysed in this study; samples 3B and 4B originate from the same donor; MD and MF:
specimens collected from two Egyptian mummies; f-samples: forensic samples
Ten human control samples (CTRL) from fresh blood were pooled together to provide tentative reference values (mean7SD, maximum
and minimum values observed, and number of samples tested, respectively). Source: biological source from which the DNA was
recovered; 2A: spleen; 3B: thyroid; 4B, E9 and E10: liver. Sample C13: buffy-coat prepared from a large blood donation stored at 1201C
for 2 weeks; sample C13X originates from the DNA preparation of C13 (see Section 2 for details). Age: presumptive age of the samples (in
years) before DNA extraction. FFPE tissues: dating based on the time elapsed from the surgical/autopsy collection; MD, MF: dating
obtained by archaeological methods; f-PI1, f-PI3, f-E3, f-E4: dating based on medico–legal parameters; f-E5, f-E6, f-E7: dating based on
burial time before exhumation. MW: maximumMW of the samples as assessed by 1.2% agarose gel electrophoresis. DNase I: sensitivity
of the sample to the enzyme estimated as residual EtBr fluorescence;1: full digestion;1/– partial digestion;1/- - minimal residual after
digestion; –: no digestion;  samples treated with RNase A. 260/280: OD260/OD280 ratio as assessed by NanoDrop analysis. UV/RT: ratio
between the total DNA concentration assessed by spectrophotometry at 260 nm and the human DNA amount estimated by Real-Time
PCR.; –: no human DNA identified. [C1G]/4B: ratio between the [C1G]/[C1G1T1A] concentrations as assessed by CE. uDNAb: relative
area of the four canonical DNA bases as determined by CE. STR analysis: f.p.: full profile; p.p.: partial profile; u.p. unreliable profile; n.p.:
no profile (see Section 3 for details).
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3 Results and discussion
3.1 CE
Previous data [3, 19, 20, 38] described the presence of many
different molecular products of bases modification in DNA
damaged samples. A number of transformations have been
shown to lead from the four bases to products of known and
still unknown molecular structure [38]. The characterisation
of these compounds and the study of their chemical origin
have been undertaken since years, but it is still the subject of
thorough investigations [39, 40]. For these reasons, it is
compelling to set up efficient methods to separate simulta-
neously as many bases analogues as possible in a single run
when analysing potentially damaged samples. Since preli-
minary experiments following published protocols [23–32, 36]
showed unsatisfactory separation of the nine purinic–pyr-
imidinic compounds of the MSM, we optimised the present
protocol which is based upon micellar conditions at high
concentration of SDS (0.3M) at the pH of 8.4 while the other
pH conditions tested (8.1 and 9.0) were discarded because of
poor selectivity; the analytes at pH 8.1 eluted too early while
at pH 9.0 they eluted at higher retention times but were
poorly resolved. In addition, since MDQ apparatus allows
currents up to 300 mA, a voltage of 20 KV assured the base-to-
base separation of the sharp peaks shown in Fig. 1. Moreover,
as shown in Fig. 1, the CE analysis of the blank extraction
controls evidences the presence of the internal standard
(5-Br-U) and of a system peak at about 9.6–10.4min, always
preceding U (if present) of about 0.3min.
The order of the elution of the analytes is reported in
Table 3 and shows the precision of the qualitative analysis
obtained in 44 runs of a single prolonged session. The
intermediate precision (RSD%) of inter-session experiments
increased up to 10–15% because of factors such as the
change of the capillary with time (and the need to equili-
brate it by several runs) and the stability of the buffer (no
more than 2 wk at room temperature).
The precision of the measurement of the concentrations
of the TSS in intra day test is reported in Table 1 while CV
% was o10 for each analyte in inter days tests. Replicate
analyses of the TSS had to be performed during each
working session, since the absorbance of the DNA bases
could be influenced by several factors such as the analytical
wavelength, the running buffer composition, and the
clearness of the capillary window.
The LOQ was assessed at 12 mmol/L for every base. The
LODs are reported in Table 1 and are in agreement with
those previously described in other biomedical studies,
which used CE for the analysis of DNA-related products
[23–32, 36].
The complete hydrolysis of 1 mg of human DNA is
calculated to give, in a final working volume of 25 mL, a
solution where C, G, A, and T are about 24.7, 24.7, 35.5, and
35.5 mmol/L, respectively. Therefore, the LOQ of 12 mmol/L
is suitable for determining the levels of bases expected from
DNA samples having a nominal concentration of less than
1 mg. The presented protocol, however, tested for sensitivity
as shown in Table 1, allowed the detection of the bases after
the hydrolysis of about 100 ng of human control DNAs.
Nevertheless, since modified products of the DNA bases
may occur at levels much lower than those of the parent
compounds, and thus possibly could not be detectable,
higher amounts of genetic material (2–5 mg) were employed
in this study.
As mentioned above, the human DNA is characterised
by a content of about 41% in terms of C and G (or C1G%)
[41]. In the present study the C1G% found in fresh control
samples (Table 2) was in excellent agreement with this
reference data. This observation evidences that the proposed
procedure is indeed a trustful mean for evaluating the
primary structure composition of DNAs.
This was further confirmed by the estimation of the
method accuracy after hydrolysing known amounts of
control DNAs. Based on the calculations detailed above, the
recovery of DNA resulted 0.7970.07 (N5 10) with
uDNAb40.99 (see trace c of Fig. 1).
Since reliable results were obtained from the controls,
CE analysis was applied to the 16 aged samples. All these,
except C13 and the derived sample C13X, exhibited more
complex pherograms (see Figs. 2 and 3 compared with
Fig. 1) providing with several data on their chemical
composition (see Tables 2 and 4). All these 14 samples, in
fact, exhibited lower relative amounts of the four canonical
DNA bases (uDNAb) and several additional peaks among
which U, deriving from the deamination of C, was identified
in eleven DNA samples. H and X were found in only two
Figure 1. CE analysis of reference solutions MSM (A), blank
extraction control (B), and control DNA (C). Peak m is 5-methyl-
Cytosine. X-axes: retention times in minutes. Y-axes: milli-
absorbance units (mAU). A system peak is shown by the arrows.
Electrophoresis 2009, 30, 3986–39953990 P. Fattorini et al.
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
and, respectively, five samples providing further evidences
that these intermediates are instable along the catabolic
pathway of the purine compounds [3]. Regrettably, the base
analogues commercially available as reference compounds
are only a few, and no identification of the remaining peaks
is possible. However, they are most likely products of the
bases modification.
Samples f-PI1 and f-PI3, previously analysed by HPLC/
MS [33], showed a good correspondence in terms of uDNAb
(at that time, the values were 0.930 for f-PI1 and 0.907 for
f-PI3). This observation should be considered as a further
demonstration of the present procedure accuracy as two
different techniques like HPLC/MS and CE/UV provided
consistent data on the same samples analysed in different
laboratories and times.
CE, however, as well as GC/MS and HPLC/MS,
provides information on the N-rings still present along the
DNA backbones recovered by ethanol precipitation. All these
chemical methods are unable to distinguish human DNA
from exogenous (bacterial/fungal) contamination and to
detect the presence of apurinic–apyrimidinic sites which are
well-documented changes even in vivo physiological condi-
tions [11]. This last observation implies that the actual
damage in aged samples could be higher than what assessed
by the methods mentioned above.
3.2 Identification and quantification of the nucleic
acids
Degraded UV-fluorescent material was recovered from each
of the 16 aged samples as visualised after agarose gels
electrophoresis in presence of Ethidium Bromide (see
Fig. 4). The degree of degradation varied among samples.
Six out of them showed a substantial reduction of the MW
below 400 bp (see Table 2). In order to exclude that the
observed fluorescence could arise from unknown contami-
nants, aliquots of each sample were incubated in presence of
the endonuclease DNase I, as already described [33]. This
enzyme completely digested the UV-fluorescent material
recovered from eight samples while a consistent reduction
of the signal was observed for five samples (see Table 2). It is
noteworthy that three samples from FFPE tissues (2A, 3B
and 4B) were resistant to the DNase I treatment (see Fig. 4)
but were completely digested when RNAse A was added.
Similarly, the addition of RNase A eliminated the residual
Table 3. Analytes elution order, average retention times and corresponding system precision, as evaluated by the repeatability of
measurements in a single prolonged analytical session
Analyte rt7SD (min) Repeatability (RSD(%)) Number of measurements
Uracil 9.770.1 1 22
Cytosine 11.070.3 3 44
Xanthine 11.570.2 1 13
Guanine 13.370.5 4 44
Thymine 14.070.6 4 44
Adenine 16.270.8 5 44
Hypoxanthine 17.070.5 3 13
5-Methyl-cytosine 18.170.4 2 8
5-Bromo-uracil 2171 5 19
rt, average retention time calculated based on measurements on both reference solutions and authentic samples.
Figure 2. CE analysis of four aged samples analysed in this
study. (A): sample MD; (B): sample MF; (C): sample f-E3; (D):
sample E9. These samples always provided more complex
pherograms as compared with the controls (see trace c of Fig. 1
and text). U is a common finding in the samples (see Table 4).
5-Br-U: internal standard. X-axes: retention times in minutes.
Y-axes: mAU.
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amount of fluorescence showed by the five samples only
partially digested by DNAseI. This fluorescent RNAse A
sensitive material could correspond to RNA or, more likely,
reflect a damaged structure of the DNA [42]. These results
showed that the UV-fluorescent material recovered from the
aged samples were indeed nucleic acids.
All the aged samples were thus quantified by spectro-
photometry at OD260, which provided values ranging from
36 ng/mL to 3.7 mg/mL. As reported in Table 2, the OD260/
OD280 ratios were always anomalous if compared with the
controls. Since the spectrophotometric determination does
not discriminate the human DNA from exogenous
contaminants such as bacterial and fungal DNA, 40–50 ng
of each extract were then quantified by a Real-Time PCR
procedure. This assay, targeting a 62 bp human DNA single
copy sequence, identified human DNA in 11 out of 16
samples with a concentration varying from very low (f-E3:
7 pg/mL) to quite relevant amounts (f-PI1: 2.5 mg/mL). No co-
extracted inhibitors of the amplification process were iden-
tified in the aged samples as assessed by the cycle threshold
values (o29 cycles) of the IPC probe. No amplification
signals were observed in blank extraction control samples.
The ratios between the concentration assessed by spec-
trophotometry at OD260 and the human amount estimated
by Real-Time PCR for each sample are shown in Table 2
where they are listed in the UV/RT column. UV/RT ratios
within the range of the controls (minimum 0.5, maximum
3.2, mean7SD 1.2708) were found only for samples f-PI1,
Figure 3. CE analysis of sample 4B from 8 to 20min (A). Trace b
shows the same sample spiked with 1/10 (v/v) of 4MBS. The
addition of this standard confirmed only the presence of U. m:
5-methyl-Cytosine. Trace c shows the analysis of sample f-E7
from 18 to 35min. Several unknown late eluting substances are
observed. X-axes: retention times in minutes. Y-axes: mAU.
Table 4. Results of the CE analysis
Sample C G T A OIA
2A 0.118 0.313 0.005 0.236 U
3B 0.072 0.305 o LOQ 0.290 U
4B 0.105 0.294 0.007 0.280 U
MD 0.045 0.130 o LOQ 0.154 U, X
MF 0.094 0.233 0.043 0.261 U
f-PI1 0.127 0.326 0.062 0.361 U, X
f-PI3 0.105 0.258 0.190 0.433 –
f-E3 0.115 0.279 0.088 0.380 U
f-E4 0.105 0.249 0.197 0.408 H, X
f-E5 0.021 0.023 0.022 0.029 –
f-E6 0.091 0.145 0.102 0.147 U
f-E7 0.058 0.081 0.049 0.073 U, X
E9 0.119 0.333 0.035 0.326 U
E10 0.131 0.284 0.099 0.438 U, H, X
C13 0.107 0.217 0.229 0.436 –
C13X 0.111 0.203 0.223 0.437 –
CTRL –
Mean7SD 0.11470.006 0.2570.02 0.2170.01 0.4370.01
Max 0.124 0.27 0.23 0.45
Min 0.105 0.19 0.19 0.42
N 10 10 10 10
Relative area of the each DNA base (C, G, T and A) found in the samples, calculated as ratio between the area of the individual compound
to the sum of the areas of the peaks of the four bases
Anomalous values with lower relative amounts of T are always present in aged samples. OIA: other identified analytes. CRTL: control
samples.
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f-PI3 and C13. In the remaining extracts, the human DNA
fraction resulted to be only a minor component. For exam-
ple, the human fraction in sample f-E3 was very limited, as
assessed by the high value of the ratio (i.e. 6985). No
templates were found in the two Egyptian mummies and in
three FFPE samples (2A, 3B and 4B).
Lack of sensitivity to PCR amplification can be due to
several reasons with the availability of preserved templates
remaining the first [1, 2]. In the case of aged/forensic
samples, exogenous (bacterial/fungal) contamination can be
a relevant source of UV-absorbing substances. However, it
has been already shown by hybridisation techniques [33]
that such contamination provides only a partial explanation
for the bulks of genetic material. In our samples, even
though contamination could not be excluded at all, both
fragmentation and DNA chemical decay provide more
reasonable explanations for no or low sensitivity to the Real-
Time PCR quantitative assay.
3.3 STR typing
STR typing in replicate tests was performed on the 11
samples wherein the presence of human amplifiable DNA
was determined by the Real-Time PCR assay.
Full profiles, defined by the complete and reliable typing
of the 16 genetic markers included in the kit, were obtained
analysing samples f-PI1, f-PI3, f-E4 and C13 while no profile
was the result of sample f-E3 and E10 typing. A partial profile,
characterised by the amplification of only few STRs in the low
MW range (D8S1179, D3S1358, D19D433, vWA, D5S818 and
amelogenin loci), was seen amplifying sample E9. Finally, the
Figure 4. Agarose gel electrophoresis of samples 3B and E9. N:
native sample; D: digestion with DNase I; R: digestion with
RNase A. DNA (ctrl): high MW DNA from control sample; RNA
(ctrl): 16S-3S rRNA; 1: l/HindIII; 2: l/HindIII plus Easy ladder.
Sample 3B shows no sensitivity to DNase I while it is fully
digested by RNase A. Sample E9 shows a minimal residual
fluorescence only after incubation with DNaseI (see also Table 2).
Figure 5. STR profile obtained from sample f-E7 (20 years old femur of a male individual). Several PCR artefacts peculiar of low copy
number DNA can be scored: additional allelic peaks and off-ladder (OL) alleles (pointed by the arrows) were seen for D8S1179, D19S433
and vWA loci. The genetic typing of the sample provided only an AMEL (amelogenin) X-specific peak. This finding could be explained by
a complete drop-out of the amelogenin Y peak (shown by the dotted box). An asterisk shows artificial peaks known as ‘‘dye blobs’’. The
cut-off for an unambiguous allelic call was set up to4100 relative fluorescence units (Y axes).
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STR typing of samples f-E3, f-E6, f-E7 and C13X showed low-
quality profiles typical of the LCN-DNA condition (low copy
number) [43] with extra alleles, allele imbalance and allelic
drop-out as shown in Fig. 5. These PCR artefacts affected the
reproducibility of the genetic results whose quality was not
improved even by increasing the DNA amount of template.
The inability of assessing a consensus genetic profile from
the replicate amplifications of these samples led us to define
these results as unreliable profiles.
A common characteristic of all the samples we investi-
gated is to exhibit chemical–physical features pointing to a
damage of the DNA primary structure as compared with the
controls. However, none of the data on the chemical–phy-
sical features of the nucleic acids (MW, sensitivity to
nucleases, OD260/280 and CE data) investigated here seems
to be related to the presumptive dating of the samples. This
provides further evidences supporting data, which indicate
that environmental conditions play a major role in assuring
DNA stability [35, 44].
The five samples which gave reliable STR profiles (full
or partial) showed uDNAb values higher than 0.81. The four
full profiles originated from four 0.05–0.1-year-old samples
showing UV/RT ratios close to the range of the controls and
uDNAb values higher than 0.876. The partial profile was
obtained from a 5-year-old sample with uDNAb of 0.813 and
UV/RT ratio about 60 times higher than the controls. All the
remaining samples were 1–20 years old and gave no or
unreliable STR profiles.
None of the features studied in Table 2 provides a priori,
by itself and alone, indication on the successful and reliable
outcome of the STR typing. In addition, neither the
combined evaluation of two or more of these features helps
in this task. For example, sample C13X gave unreliable
profiles in spite of unquestionable values provided by CE
analysis ([C1G]/4B: 0.405; uDNAb: 0.974) and a UV/RT
ratio about 60-fold the reference value of the controls. A
possible explanation for the STR failure of this sample can
be likely found in its heavy fragmentation (MWo0.4 kb).
Similarly, sample E3 had a relatively high uDNAb value
(0.862) and a MWo2.0 kb but no STR profiles were ever
gathered. In this case, the extremely low fraction of PCR-
sensitive human DNA (as shown by a UV/RT ratio of 6985)
could explain the STR typing failure.
On the contrary, a very clear finding is that samples
having uDNAb values lower than 0.81 never showed full or
partial profiles. This is in agreement with other data show-
ing that the integrity of the template plays a fundamental
role in the PCR success [1, 2, 4, 5] and supports a correlation
between an unsuccessful and/or unreliable outcome of the
STR typing and low uDNAb values.
4 Concluding remarks
This study reports on the use of CE as tool for studying the
primary structure of the genetic material recovered from
aged specimens. The data obtained by PCR, together with
the results achieved from classical molecular assays such as
agarose gel electrophoresis, enzymatic digestions and UV
spectrophotometry, were evaluated in their consistency with
the results of CE.
It is well known that the successful and reliable
outcome of DNA amplification depends basically on the
availability of complete templates, while severe molecular
damage of the primary structure of the DNA can lead both
to PCR failure and artefacts [1, 4, 5, 20, 45]. Moreover, DNA
damage inevitably accumulates in post mortem tissues and
thus the need of authenticity criteria in evaluating the
genetic data obtained from aged samples is a relevant
concern [3, 44].
The assessment of the amount of canonical DNA bases
(uDNAb) still present alongside the DNA chain has been
already described by HPLC/MS [17, 20, 45], but the CE
method proposed here is simpler and inexpensive, provid-
ing reliable indication on the integrity of the basic moieties
of the DNA samples.
The presented data suggest that uDNAb value is useful
in the critical evaluation of the reliability of STR profiles,
and can be considered as further quality criterion of the
genetic testing.
First, full STR profiles arose only from samples whose
decay was limited as indicated by a high uDNAb value.
Secondly, all samples, which never gave genetic results, had
low uDNAb values, with an aging ranging from 1 to 2600
years. However, no relation between the aging of the sample
and its chemical decay has been found as yet [3, 17, 19].
Sample C13X seems to provide an example of conflict-
ing data because an unreliable genetic profile was found in a
rather recent specimen with a high uDNAb value. This
could be explained assuming a fragmentation of the sample,
as indicated by the low MW of the DNA extracted (o0.4 kb),
which caused the unsuccessful outcome of the PCR analysis
owing to the absence of human-sensitive sequences with
suitable MW [1, 3]. An additional explanation could be the
presence of apurinic–apyrimidinic sites [1, 3] within the
molecular frame, which is undetectable by the present
method.
Hence, when a full STR profile is obtained from
samples having low uDNAb, a recent contamination should
be at least taken into account since a successful genetic
outcome should not be expected from heavily damaged
samples.
In conclusion, even if the number of samples studied
here is limited, the uDNAb value measurement can be
proposed as a scientific authenticity criterion in the evalua-
tion of genetic data obtained from post mortem samples
independently from their aging.
The major limit of the CE/UV method described here is
the relatively high amount of sample required for one
analysis, so that very limited specimens cannot be studied.
As a future perspective, a larger number of aged samples
will be considered to validate the criterion proposed here
also evaluating a complete set of genetic typing including
miniSTR, SNPs, mtDNA assays and clone sequencing.
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